BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12077735)

  • 1. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
    Elian KM; Hoffer LJ
    Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease.
    Hoffer LJ; Elian KM
    Clin Invest Med; 2004 Feb; 27(1):10-3. PubMed ID: 15061579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN; Mamer OA; Hoffer LJ
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease.
    Hoffer LJ; Djahangirian O; Bourgouin PE; Eid J; Saboohi F
    Metabolism; 2005 Oct; 54(10):1362-7. PubMed ID: 16154437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
    Obeid R; Kuhlmann MK; Köhler H; Herrmann W
    Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
    Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
    J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin B12 on total plasma homocysteine concentration in folate-replete hemodialysis patients.
    Arnadottir M; Hultberg B
    Clin Nephrol; 2003 Mar; 59(3):186-9. PubMed ID: 12653261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
    Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study.
    Pöge U; Look M; Gerhardt T; Klehr HU; Sauerbruch T; Woitas RP
    Ren Fail; 2004 Nov; 26(6):703-8. PubMed ID: 15600263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.